Although there was no significant effect of this drug on the proliferation-inducing activity of CM from unprogrammed macrophages, the STAT3 inhibitor blocked the induction of pro-proliferative activity caused by ADPKD-CM-mediated programming (Fig. 5B). This evidence concerns the gene STAT3 and autosomal dominant polycystic kidney disease.